Global brand in pharmaceuticals and diagnostics, Roche Diagnostics, is set to expand its operations in Nigeria.
This is coming at a time when the country’s challenging business environment has forced some multinational companies, especially in the manufacturing and healthcare sectors, to scale back or exit Nigeria completely.
Speaking via a press statement, Roberto Taboada, country manager at Roche Diagnostics, Africa, said that the decision reinforces its commitment to expanding access to high-quality diagnostics across the continent.
He stated that his company sees Nigeria as a vital market for both healthcare impact and long-term investment, hence the wise decision to expand.
According to him, the expansion is in alignment with its one-decade diagnostics strategy for Africa, which aims to boost access to in-vitro diagnostics (IVD) tenfold.
He concluded by saying that Nigeria represents a magnificent opportunity for investment, which is why Roche will keep committing to exploring what the country has to offer.
“Nigeria is the second-largest economy on the continent and one of the most populous countries in Africa. Looking at the long term, it’s clear there is a critical need to improve healthcare access and outcomes for the Nigerian population,” he said.
Also speaking, director, strategy and innovation at Roche Diagnostics, Africa, Jonathan Keytel said that the expansion would solidify the company’s determination to keep delivering lasting healthcare solutions that will save lives.
“With this launch, we strengthen our role in delivering innovative diagnostics solutions that improve healthcare outcomes for more patients where it is needed most
Nigeria is a critical market, and this investment supports our long-term vision for healthcare in Africa,” he added.
